| Primary |
| Renal Impairment |
50.0% |
| Cardiac Failure |
12.5% |
| Hypertension |
12.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
12.5% |
| Type 2 Diabetes Mellitus |
12.5% |
|
| Dyspnoea |
33.3% |
| Renal Failure |
33.3% |
| Renal Failure Acute |
33.3% |
|
| Secondary |
| Hypertension |
18.6% |
| Electrolyte Substitution Therapy |
11.6% |
| Stupor |
7.0% |
| Coronary Artery Disease |
6.5% |
| Arthritis |
6.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.4% |
| Type 2 Diabetes Mellitus |
4.7% |
| Pain |
4.4% |
| Renal Impairment |
4.1% |
| Prophylaxis Against Transplant Rejection |
3.6% |
| Restlessness |
3.6% |
| Polyneuropathy Alcoholic |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Thrombosis Prophylaxis |
2.8% |
| Chronic Obstructive Pulmonary Disease |
2.6% |
| Depression |
2.6% |
| Hypothyroidism |
2.6% |
| Partial Seizures |
2.6% |
| Renal Hypertension |
2.6% |
| Cardiac Failure |
2.3% |
|
| Renal Failure Acute |
26.8% |
| Toxic Epidermal Necrolysis |
14.6% |
| Stevens-johnson Syndrome |
9.8% |
| International Normalised Ratio Increased |
7.3% |
| Rhabdomyolysis |
7.3% |
| Weight Increased |
7.3% |
| Hyperlipidaemia |
4.9% |
| Urethral Haemorrhage |
4.9% |
| Cerebral Haemorrhage |
2.4% |
| Dehydration |
2.4% |
| Dyspnoea |
2.4% |
| Hyponatraemia |
2.4% |
| Prothrombin Time Prolonged |
2.4% |
| Renal Failure |
2.4% |
| Suicide Attempt |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.3% |
| Drug Use For Unknown Indication |
13.7% |
| Hypertension |
10.3% |
| Type 2 Diabetes Mellitus |
4.6% |
| Renal Transplant |
4.4% |
| Atrial Fibrillation |
3.5% |
| Cardiac Failure |
3.2% |
| Immunosuppression |
2.3% |
| Pain |
2.3% |
| Ascites |
2.1% |
| Hyperparathyroidism Secondary |
1.9% |
| Renal Failure |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Diabetic Neuropathy |
1.8% |
| Non-small Cell Lung Cancer |
1.8% |
| Pneumonia |
1.8% |
| Coronary Artery Disease |
1.6% |
| Depression |
1.6% |
| Oedema |
1.6% |
| Prophylaxis |
1.6% |
|
| Hypoglycaemia |
11.9% |
| Gastrointestinal Haemorrhage |
9.5% |
| Renal Failure Acute |
8.3% |
| Weight Decreased |
8.3% |
| Pyrexia |
7.1% |
| Urosepsis |
7.1% |
| Tachycardia |
6.0% |
| Somnolence |
4.8% |
| Vomiting |
4.8% |
| Drug Interaction |
3.6% |
| Pneumonia |
3.6% |
| Shunt Occlusion |
3.6% |
| Tremor |
3.6% |
| Weight Increased |
3.6% |
| Bradyarrhythmia |
2.4% |
| Cerebrovascular Accident |
2.4% |
| Delirium |
2.4% |
| Drug Toxicity |
2.4% |
| Fluid Retention |
2.4% |
| Gastritis |
2.4% |
|
| Interacting |
| Hypertension |
30.7% |
| Type 2 Diabetes Mellitus |
15.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
11.4% |
| Renal Impairment |
11.4% |
| Ischaemic Heart Disease Prophylaxis |
9.6% |
| Hyperlipidaemia |
5.3% |
| Polyneuropathy Alcoholic |
5.3% |
| Chronic Obstructive Pulmonary Disease |
3.5% |
| Coronary Artery Disease |
3.5% |
| Pulmonary Embolism |
1.8% |
| Drug Use For Unknown Indication |
0.9% |
| Myocardial Infarction |
0.9% |
|
| Renal Failure Acute |
85.7% |
| Dehydration |
14.3% |
|
